Drug
Kk3910
Kk3910: highest development phase Phase 1, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KK3910 NCT06823947 | Phase 1 |
Latest
No recent events.
Follow Kk3910 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.